← Back to Search

Radiation

Systemic therapy plus SBRT to OM for Breast Cancer (STOMP Trial)

Phase < 1
Waitlist Available
Led By Anand Swaminath, MD,FRCPC
Research Sponsored by Juravinski Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6 12 months from sbrt treatment
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to evaluate feasibility to treat metachronous multi-site breast cancer oligometastasis with stereotactic body radiotherapy (SBRT) in patients on systemic therapy.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6 12 months from sbrt treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6 12 months from sbrt treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Technical feasibility of planning SBRT to multiple sites
Secondary study objectives
Feasibility of patient accrual: Successful accrual of 30 patients to study
Local Control: CT scan or MRI as assessed by RECIST criteria 1.1
Overall Survival (OS)
+3 more

Side effects data

From 2008 Phase 2 trial • 20 Patients • NCT00350142
15%
ulcer
10%
vomiting
5%
Perforation
5%
pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
SBRT With Gem

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Systemic therapy plus SBRT to OMExperimental Treatment1 Intervention
Stereotactic Body Radiotherapy (SBRT) up to 5 OM sites
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stereotactic Body Radiotherapy
2017
Completed Phase 2
~220

Find a Location

Who is running the clinical trial?

Toronto Sunnybrook Regional Cancer CentreOTHER
9 Previous Clinical Trials
923 Total Patients Enrolled
1 Trials studying Breast Cancer
24 Patients Enrolled for Breast Cancer
Juravinski Cancer CenterLead Sponsor
13 Previous Clinical Trials
2,315 Total Patients Enrolled
1 Trials studying Breast Cancer
630 Patients Enrolled for Breast Cancer
Anand Swaminath, MD,FRCPCPrincipal InvestigatorMcMaster University
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top